- Home
- VTS vs IGMS Comparison
VTS vs IGMS Comparison
Compare VTS & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- IGMS
- Stock Information
- Founded
- VTS 2014
- IGMS 1993
- Country
- VTS United States
- IGMS United States
- Employees
- VTS N/A
- IGMS N/A
- Industry
- VTS Oil & Gas Production
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- VTS Energy
- IGMS Health Care
- Exchange
- VTS Nasdaq
- IGMS Nasdaq
- Market Cap
- VTS 805.4M
- IGMS 962.1M
- IPO Year
- VTS N/A
- IGMS 2019
- Fundamental
- Price
- VTS $27.03
- IGMS $9.47
- Analyst Decision
- VTS Hold
- IGMS Hold
- Analyst Count
- VTS 1
- IGMS 8
- Target Price
- VTS N/A
- IGMS $14.63
- AVG Volume (30 Days)
- VTS 155.2K
- IGMS 238.9K
- Earning Date
- VTS 11-04-2024
- IGMS 11-08-2024
- Dividend Yield
- VTS 7.77%
- IGMS N/A
- EPS Growth
- VTS N/A
- IGMS N/A
- EPS
- VTS 1.45
- IGMS N/A
- Revenue
- VTS $232,520,000.00
- IGMS $2,918,000.00
- Revenue This Year
- VTS $25.43
- IGMS $298.54
- Revenue Next Year
- VTS $8.17
- IGMS N/A
- P/E Ratio
- VTS $18.68
- IGMS N/A
- Revenue Growth
- VTS 13.53
- IGMS 57.64
- 52 Week Low
- VTS $19.63
- IGMS $4.72
- 52 Week High
- VTS $27.85
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- VTS 61.71
- IGMS 28.30
- Support Level
- VTS $26.83
- IGMS $10.91
- Resistance Level
- VTS $27.60
- IGMS $16.32
- Average True Range (ATR)
- VTS 0.67
- IGMS 1.53
- MACD
- VTS 0.14
- IGMS -0.79
- Stochastic Oscillator
- VTS 75.38
- IGMS 0.80
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.